Brought to you by 
Genzyme Genetics sublicenses EGFR mutation assay to Roche
26 Jan 2011
Executive Summary
Genzyme Genetics (recently acquired by LabCorp) has sublicensed to Roche a diagnostic assay that detects mutations in the epidermal growth factor receptor (EGFR) gene. Roche has worldwide rights.
Deal Industry
- In Vitro Diagnostics
- Pharmaceuticals
-
Research, Analytical Equipment & Supplies
- PCR & Amplification Tools
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
- Pharmacogenetics-Pharmacogenomics
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com